Constella

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Linaclotide 0.29mg;  ;  

Available from:

AbbVie Limited

Dosage:

290 mcg

Pharmaceutical form:

Capsule

Composition:

Active: Linaclotide 0.29mg     Excipient: Calcium chloride dihydrate Capsugel linaclotide gelatine s 2 (18212) Hydrochloric acid Hypromellose Leucine Microcrystalline cellulose Opacode gray S-1-175002

Prescription type:

Prescription

Therapeutic indications:

CONSTELLA is indicated in adults for the treatment of: · irritable bowel syndrome with constipation (IBS-C) and

Product summary:

Package - Contents - Shelf Life: Bottle, plastic, HDPE bottle with PP CRC and silica desiccant - 4 capsules - 24 months from date of manufacture stored at or below 25°C protect from moisture - Bottle, plastic, HDPE bottle with PP CRC and silica desiccant - 30 capsules - 24 months from date of manufacture stored at or below 25°C protect from moisture

Authorization date:

2018-02-28